• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Socioeconomic Factors Impacting Development of Cardiac Disease

Opinion
Video

Financial and geographic disparities contributing to elevated risk for heart disease are explored.

This is a video synopsis/summary of a panel discussion involving Robert Groves, MD; Eugene E. Wright Jr, MD; Nancy Albert, PhD, CCNS, CCRN, CHFN, NE-BC, FAHA, FCCM, FHFSA, FAAN; Nihar Desai, MD, MPH; and Kelly Marie Axsom, MD. The panel discusses socioeconomic factors impacting heart failure risk. Wright highlights social determinants like economic and income insecurity, food insecurity, transportation challenges, education levels, lived experiences, and psychosocial stress. Wright also highlights Individuals with lower incomes have higher cardiovascular disease risk due to increased stress hormones like catecholamines and cortisol. A person’s zip code might better predict their health than genetics.

Albert expands on the patient impact, explaining how limited income can reduce access to medications, transportation, and proper nutrition. Patients may live in food deserts without access to healthy options. Many are on fixed incomes and Medicare or Medicaid and cannot easily afford new treatments. Readmissions also financially penalize hospitals, influencing their care approaches to reduce overall readmission rates. The scope of heart failure is expanding, affecting more patients nationwide. In summary, this multifactorial disease has significant individual and societal impacts that require urgent attention.

Video synopsis is AI-generated and reviewed by AJMC editorial staff.

Related Videos
Chesahna Kindred, MD, MBA, FAAD, board-certified dermatologist, Kindred Hair & Skin Center.
Stephanie L. Graff, MD, an expert on breast cancer
B. Joy Snider, MD, PhD, and Maria Lopes, MD, MS
A panel of 5 experts on Alzheimer disease
Video 2 - "Payer Needs and Strategies for Evaluating and Covering PDTs"
Video 1 - "Differentiating PDTs from Wellness Apps and Evaluating Efficacy"
Chris Pagnani, MD, PC
Video 4 - "Oral SERDs in Development for ER+/HER2- Metastatic Breast Cancer"
Video 3 - "The Role of Oral SERDs in ER+/HER2- Metastatic Breast Cancer"
Screenshot of Stephen Freedland, MD, during a video interview
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.